At present times, COVID-19 has become a global illness and infected people has increased exponentially and it is difficult to control due to the non-availability of large quantity of testing kits. Artificial intelligence (AI) techniques including machine learning (ML), deep learning (DL), and computer vision (CV) approaches find useful for the recognition, analysis, and prediction of COVID-19. Several ML and DL techniques are trained to resolve the supervised learning issue. At the same time, the potential measure of the unsupervised learning technique is quite high. Therefore, unsupervised learning techniques can be designed in the existing DL models for proficient COVID-19 prediction. In this view, this paper introduces a novel unsupervised DL based variational autoencoder (UDL-VAE) model for COVID-19 detection and classification. The UDL-VAE model involved adaptive Wiener filtering (AWF) based preprocessing technique to enhance the image quality. Besides, Inception v4 with Adagrad technique is employed as a feature extractor and unsupervised VAE model is applied for the classification process. In order to verify the superior diagnostic performance of the UDL-VAE model, a set of experimentation was carried out to highlight the effective outcome of the UDL-VAE model. The obtained experimental values showcased the effectual results of the UDL-VAE model with the higher accuracy of 0.987 and 0.992 on the binary and multiple classes respectively.
Recently, intelligent video surveillance applications have become essential in public security by the use of computer vision technologies to investigate and understand long video streams. Anomaly detection and classification are considered a major element of intelligent video surveillance. The aim of anomaly detection is to automatically determine the existence of abnormalities in a short time period. Deep reinforcement learning (DRL) techniques can be employed for anomaly detection, which integrates the concepts of reinforcement learning and deep learning enabling the artificial agents in learning the knowledge and experience from actual data directly. With this motivation, this paper presents an Intelligent Video Anomaly Detection and Classification using Faster RCNN with Deep Reinforcement Learning Model, called IVADC-FDRL model. The presented IVADC-FDRL model operates on two major stages namely anomaly detection and classification. Firstly, Faster RCNN model is applied as an object detector with Residual Network as a baseline model, which detects the anomalies as objects. Besides, deep Q-learning (DQL) based DRL model is employed for the classification of detected anomalies. In order to validate the effective anomaly detection and classification performance of the IVADC-FDRL model, an extensive set of experimentations were carried out on the benchmark UCSD anomaly dataset. The experimental results showcased the better performance of the IVADC-FDRL model over the other compared methods with the maximum accuracy of 98.50% and 94.80% on the applied Test004 and Test007 dataset respectively.
Due to the fast development of medical imaging technologies, medical image analysis has entered the period of big data for proper disease diagnosis. At the same time, intracerebral hemorrhage (ICH) becomes a serious disease which affects the injury of blood vessels in the brain regions. This paper presents an artificial intelligence and big data analytics-based ICH e-diagnosis (AIBDA-ICH) model using CT images. The presented model utilizes IoMT devices for data acquisition process. The presented AIBDA-ICH model involves graph cut-based segmentation model for identifying the affected regions in the CT images. To manage big data, Hadoop Ecosystem and its elements are mainly used. In addition, capsule network (CapsNet) model is applied as a feature extractor to derive a useful set of feature vectors. Finally, the presented AIBDA-ICH model makes use of the fuzzy deep neural network (FDNN) model to carry out classification process. For validating the superior performance of the AIBDA-ICH method, an extensive set of simulations were performed and the outcomes are examined under diverse aspects. The experimental values pointed out the improved e-diagnostic performance of the AIBDA-ICH model over the other compared methods with the precision and accuracy of 94.96% and 98.59%, respectively.
Type 2 diabetes (T2D) is a systematic chronic metabolic condition with abnormal sugar metabolism dysfunction, and its complications are the most harmful to human beings and may be life-threatening after long-term durations. Considering the high incidence and severity at late stage, researchers have been focusing on the identification of specific biomarkers and potential drug targets for T2D at the genomic, epigenomic, and transcriptomic levels. Microbes participate in the pathogenesis of multiple metabolic diseases including diabetes. However, the related studies are still non-systematic and lack the functional exploration on identified microbes. To fill this gap between gut microbiome and diabetes study, we first introduced eggNOG database and KEGG ORTHOLOGY (KO) database for orthologous (protein/gene) annotation of microbiota. Two datasets with these annotations were employed, which were analyzed by multiple machine-learning models for identifying significant microbiota biomarkers of T2D. The powerful feature selection method, Max-Relevance and Min-Redundancy (mRMR), was first applied to the datasets, resulting in a feature list for each dataset. Then, the list was fed into the incremental feature selection (IFS), incorporating support vector machine (SVM) as the classification algorithm, to extract essential annotations and build efficient classifiers. This study not only revealed potential pathological factors for diabetes at the microbiome level but also provided us new candidates for drug development against diabetes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.